HealthEconomics.com – A Scientist.com Company Publish Date: August 26th, 2022 Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to the brain and spinal cord[…]
Inside Precision Medicine Published Online: August 18, 2022 Read the Full Article >> Artificial intelligence (AI) has promised major breakthroughs in clinical development success. While the hype has sometimes seemed overblown, AI is starting to deliver on those promises through real-world impact. AI is not a silver bullet for all challenges, but in specific applications,[…]
Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]
Sage Journals Published June 22, 2022 Read the Full Manuscript>> Abstract Background Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective To validate a machine learning model to estimate EDSS scores[…]
Tue. June 28, 2022 11:00AM – 12:00PM Register >> Identifying patients in real-world data contexts can be difficult, especially when clinical coding is imprecise or unavailable. This webinar will dive into how artificial intelligence tools and real-world data can provide powerful solutions to these challenges. We will discuss how to approach: Conditions with new, underutilized[…]
